Background Bullous pemphigoid (BP) in infants is a rare but increasingly reported
autoimmune blistering skin disease. Autoantibody reactivity is usually poorly characterized …

Importance Bullous pemphigoid (BP) has been previously described to develop after
vaccination in 26 patients. Immunoblotting or enzyme-linked immunosorbent assays …

A 4-month-old infant was observed with an acute itchy bullous dermatosis, predominantly
involving the extremities, which revealed a dermal infiltrate rich in eosinophils, C3 deposits …

The development of infantile and childhood bullous pemphigoid following vaccination was
already documented in several cases. This post-vaccination autoimmune phenomenon is …

Bullous pemphigoid (BP) is an autoimmune bullous disorder mostly encountered in the
elderly with age of onset more than 60 years and incidence peak in 80s and older. Though it …

An autoimmune bullous disorder encompasses a heterogeneous group of disorders
characterized by the presence of blisters and autoantibodies against structural components …

Bullous pemphigoid (BP) is an acquired sub-epidermal immune-mediated blistering disease
associated with a humoral and cellular response directed against self-antigens. Childhood …

Dermatology nurses need access to evidence-based information to remain current in safe
nursing practice. Many dermatology nurses do not have access to this information through …